Coronary artery disease (CAD) is a major health issue in both women and men, however the time of its onset, the course of the disease the presentation of clinical symptoms and the response to therapy show gender-specific features.
1,2 Fibrinogen and the fibrinolytic inhibitor PAI-1 are the most well-established hemostatic risk factors for CAD and gender-related differences could also be demonstrated concerning the effects of these risk factors.
3,4 Factor XIII (FXIII) is intimately related to fibrinogen and is a key factor in the regulation of fibrinolysis.
5 Its active form (FXIIIa) cross-links fibrin α-and γ-chains and covalently attaches α2-plasmin inhibitor to fibrin. In this way, FXIIIa mechanically stabilizes fibrin and protects it from the fibrinolytic system.
In the present study FXIII activity and antigen levels were measured in a large number of patients with suspected CAD using REA-chrom FXIII and R-ELISA FXIII (Reanal) reagent kits, respectively. 6,7 Nine hundred and fifty-five consecutive patients admitted for coronary angiography were recruited for the study. Patients with ≥50% stenosis in a major coronary artery or in one of its branches were defined as having coronary sclerosis (CS + ) were compared. Ethical approval was obtained from the University of Debrecen Ethics Committee, and the subjects gave informed consent.
Serum cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, apoAI, apoB, lipoprotein (a), homocysteine and fibrinogen were determined by routine laboratory methods. Age, current smoking, body mass index, and the presence of hypertension and diabetes mellitus were recorded. The median age of the women was 57.7 years; 91.7% were menopausal and they were not on hormonal replacement therapy.
Neither FXIII activity nor FXIII antigen levels of the clinical controls differed significantly from those measured in the healthy reference population. Multiple linear regression demonstrated that gender, smoking, cholesterol and fibrinogen levels were independently associated with FXIII activity and FXIII antigen levels, and mean FXIII levels adjusted for these parameters were used in the analysis.
CS and/or MI did not influence adjusted FXIII levels in either the overall population or in the male patients ( Table 1) . The relationship between CAD and plasma FXIII levels has been investigated in only a few studies including relatively low numbers of males or predominantly male patients. [8] [9] [10] The basically negative outcome of these studies agrees well with the results of the present study. The effect of CS or MI on FXIII levels in females has not been addressed previously. CS alone did not have an effect in females, either. However, when CS + females with and without a history of MI were compared, statistically significant elevations of both FXIII activity and antigen levels were observed in the MI ). Elevated FXIII levels were associated with a significantly increased risk of MI in women, but not in men.
On the basis of these results, elevated FXIII can be regarded as a gender (female)-specific risk factor for MI, and FXIII determination could be a candidate for inclusion in the risk stratification for women. By preventing plasmin-induced degradation of fibrin, elevated FXIII levels could play a role in sustaining newly formed thrombus in coronary arteries. Although it remains to be seen why such a mechanism operates only in women, the results support the view that the clotting system plays a more prominent role in the development of MI in females than in males.
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